C4 Therapeutics, Inc. — Form D

C4 Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-11. The offering totals $73.5M, of which $70.3M was reported sold. Industry: Biotechnology.

Offering

Filed: 2016-01-11
Form: D
Accession: 0001662579-16-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $73.5M
Amount sold: $70.3M
Remaining: $3.2M
Investors: 55
Date of first sale: 2015-12-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-254901

Issuer

Name: C4 Therapeutics, Inc.
CIK: 0001662579
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2015
Address: 675 West Kendall Street, Cambridge, MA, 02142
Phone: (202) 421-7994

Officers, directors & promoters (14)

Name	Role	Location
Kenneth M Anderson	Director	Cambridge, MA
Bihua M Chen	Director	Cambridge, MA
Alain Cohen	Director	Cambridge, MA
Marc Cohen	Director	Chicago, IL
Bruce M Downey	Director	Cambridge, MA
Jay M Eastman	Director	Pittsford, NY
Jason Fisherman	Director	Woodbridge, CT
Ronald W Kaiser	Director	Foster City, CA
Elena M Prokupets	Director	Cambridge, MA
Malcolm S Salter	Director	Cambridge, MA
William M Scalzulli	Director	Cambridge, MA
Miles M Stuchin	Director	Cambridge, MA
Marc Cohen	Executive Officer	Chicago, IL
Jason Fisherman	Executive Officer	Woodbridge, CT

More